A phase I/II clinical trial of cisplatin, and raltitrexed in patients with metastatic breast cancer refractory to anthracycline therapy.

被引：0
|
作者：
Rapoport, B
Mahomed, R
Uys, A
机构：
[1] Univ Pretoria, Dept Med Oncol, ZA-0001 Pretoria, South Africa
[2] Med Oncol Ctr Rosebank, Johannesburg, South Africa
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
140P
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [41] A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma
    Tiersten, AD
    Nelsen, C
    Talbot, S
    Vahdat, L
    Fine, R
    Troxel, A
    Brafman, L
    Shriberg, L
    Antman, K
    Petrylak, DP
    CANCER, 2003, 97 (03) : 537 - 544
  • [42] Gefitinib in Combination with Gemcitabine and Vinorelbine in Patients with Metastatic Breast Cancer Pre-treated with Taxane and Anthracycline Chemotherapy: A Phase I/II Trial
    Gioulbasanis, Ioannis
    Saridaki, Zacharenia
    Kalykaki, Antonia
    Vamvakas, Lambros
    Kalbakis, Kostas
    Ignatiadis, Michail
    Amarantidis, Kyriakos
    Kakolyris, Stylianos
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    ANTICANCER RESEARCH, 2008, 28 (5B) : 3019 - 3025
  • [43] Phase I/II Trial of Vinorelbine and Sorafenib in Metastatic Breast Cancer
    Luu, Thehang
    Frankel, Paul
    Chung, Cathie
    Chow, Warren
    Mortimer, Joanne
    Hurria, Arti
    Somlo, George
    CLINICAL BREAST CANCER, 2014, 14 (02) : 94 - 100
  • [44] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Hugo E. R. Ford
    Yoon-Sim Yap
    David W. Miles
    Andreas Makris
    Marcia Hall
    Liz Miller
    Mark Harries
    Ian E. Smith
    Stephen R. D. Johnston
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 809 - 815
  • [45] A phase I clinical trial of entinostat and lapatinib in patients with trastuzumab refractory HER2-positive metastatic breast cancer
    Willey, Jie
    Alvarez, Ricardo H.
    Booser, Daniel J.
    Giordano, Sharon H.
    Gonzalez-Angulo, Ana M.
    Murray, James L.
    Valero, Vincente
    Lee, Jangsoon
    Ueno, Naoto T.
    Jackson, Summer A.
    Faruqi, Fahad A.
    CANCER RESEARCH, 2015, 75
  • [46] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Ford, Hugo E. R.
    Yap, Yoon-Sim
    Miles, David W.
    Makris, Andreas
    Hall, Marcia
    Miller, Liz
    Harries, Mark
    Smith, Ian E.
    Johnston, Stephen R. D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (06) : 809 - 815
  • [47] Docetaxel plus vinorelbine in patients with metastatic breast cancer progressing after anthracycline therapy. Preliminary results
    Cuevas, JM
    Baena, JM
    Espinosa, E
    Centellas, M
    Dorta, J
    Janariz, J
    Vivanco, GL
    Madronal, C
    Baron, MG
    Milla, A
    ANNALS OF ONCOLOGY, 1998, 9 : 20 - 20
  • [48] Ensituximab (E) in patients (pts) with refractory metastatic colorectal cancer (mCRC): Results of a phase I/II clinical trial.
    Kim, Richard D.
    Arlen, Philip M.
    Tsang, Kwong Y.
    Mavroukakis, Sharon
    Zaki, Anjum
    Cui, Karen
    Azad, Nilofer Saba
    Tan, Benjamin R.
    Poplin, Elizabeth
    Morse, Michael
    Beg, Muhammad Shaalan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Imatinib Mesylate in Combination with Vinorelbine for Patients with Metastatic Breast Cancer An Ongoing Phase I/II Clinical Trial.
    Mundhenke, C.
    Schem, C.
    Bauerschlag, D. O.
    Weigel, M. T.
    Hilpert, F.
    Eidtmann, H.
    Tiemann, K.
    Muth, M.
    May, C.
    Hanson, S.
    Jonat, W.
    Maass, N.
    CANCER RESEARCH, 2011, 71
  • [50] Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer
    Kaufman, D
    Raghavan, D
    Carducci, M
    Levine, EG
    Murphy, B
    Aisner, J
    Kuzel, T
    Nicol, S
    Oh, W
    Stadler, W
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) : 1921 - 1927
12345